Top

Published in:

01-06-2011

New Approaches to Quantifying Sympathetic Nerve Activity

Authors: Sandra L. Burke, Elisabeth Lambert, Geoffrey A. Head

Published in: Current Hypertension Reports | Issue 3/2011

Abstract

The importance of the sympathetic nervous system in the pathophysiology of human and experimental models of hypertension is well established. Underpinning recent advances has been direct recording from sympathetic nerves via implanted electrodes in animals or microneurography in human subjects. However, the limited life of a recording electrode and the prolonged nature of the development of hypertension bring with it the difficulty of comparing sympathetic nerve activity between groups. New developments in high-frequency radiotelemetry in animals have heralded a new age in long-term sympathetic recordings ideal for hypertension research. Standard multifiber recordings in human and animal studies have provided information about the frequency and amplitude of sympathetic bursts. Characterization of sympathetic output is now possible from new techniques of determining single-unit firing frequency, firing probability, and the number of spikes generated per cardiac interval. These have led to a better understanding of sympathoactivation in hypertension and its underlying mechanisms.

Korner P. Essential hypertension and its causes: neural and non neural mechanisms. New York: Oxford University Press; 2007.

Esler M. Sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases. J Cardiovasc Pharmacol. 1995;26:S24–8.PubMed

Ferrier C, Jennings GL, Eisenhofer G, Lambert G, Cox HS, Kalff V, et al. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens. 1993;11:1217–27.PubMedCrossRef

Ming EE, Adler GK, Kessler RC, Fogg LF, Matthews KA, Herd JA, et al. Cardiovascular reactivity to work stress predicts subsequent onset of hypertension: the Air Traffic Controller Health Change Study. Psychosom Med. 2004;66:459–65.PubMedCrossRef

Matthews KA, Katholi CR, McCreath H, Whooley MA, Williams DR, Zhu S, et al. Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation. 2004;110:74–8.PubMedCrossRef

Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81.PubMedCrossRef

Baumert M, Lambert GW, Dawood T, Lambert EA, Esler MD, McGrane M, et al. Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol. 2009;297:H674–9.PubMedCrossRef

Judy WV, Watanabe A, Henry DP, Besch HR, Murphy WR, Hockel GM. Sympathetic nerve activity: role in regulation of blood pressure in the spontaneously hypertensive rat. Circ Res. 1976;38:II-21–9.

Tuncel M, Augustyniak R, Zhang W, Toto RD, Victor RG. Sympathetic nervous system function in renal hypertension. Curr Hypertens Rep. 2002;4:229–36.PubMedCrossRef

10.

Dampney RA, Horiuchi J, Killinger S, Sheriff MJ, Tan PS, McDowall LM. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin Exp Pharmacol Physiol. 2005;32:419–25.PubMedCrossRef

11.

Eilam R, Malach R, Bergmann F, Segal M. Hypertension induced by hypothalamic transplantation from genetically hypertensive to normotensive rats. J Neurosci. 1991;11:401–11.PubMed

12.

Head G, Chatzivlastou K, Lukoshkova E, Jennings G, Reid CM. A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings. Am J Hypertens. 2010;23:1074–81.PubMedCrossRef

13.

• Davern PJ, Nguyen-Huu T, La Greca L, Head GA. Role of the sympathetic nervous system in Schlager genetically hypertensive mice. Hypertension. 2009;54:852–9. These investigators determined that in the Schlager hypertensive mouse, the hypertension is largely attributable to SNS activity. The hypertension was associated with greater activation of neurons in brain regions that are critical for the regulation of cardiovascular autonomic function. PubMedCrossRef

14.

Davern PJ, Jackson KL, Nguyen-Huu T, La Greca L, Head GA. Cardiovascular reactivity and neuronal activation to stress in Schlager genetically hypertensive mice. Neuroscience. 2010;170:551–8.PubMedCrossRef

15.

Davern PJ, Jackson KL, Nguyen-Huu T, La Greca L, Head GA. Cardiovascular responses to aversive and non-aversive stressors in Schlager genetically hypertensive mice. Am J Hypertens. 2010;23:838–44.PubMedCrossRef

16.

Davern PJ, Head GA. Role of the medial amygdala in mediating responses to aversive stimuli leading to hypertension. Clin Exp Pharmacol Physiol. 2011;38(2):136–43.PubMedCrossRef

17.

Garrison RJ, Kannel WB, Stokes 3rd J, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med. 1987;16:235–51.PubMedCrossRef

18.

Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M. Interactions between leptin and the human sympathetic nervous system. Hypertension. 2003;41:1072–9.PubMedCrossRef

19.

Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, et al. Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999;17:1125–33.PubMedCrossRef

20.

Eikelis N, Esler M. The neurobiology of human obesity. Exp Physiol. 2005;90:673–82.PubMedCrossRef

21.

Antic V, Kiener-Belforti F, Tempini A, Van Vliet BN, Montani JP. Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits. Am J Hypertens. 2000;13:556–9.PubMedCrossRef

22.

• Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL, Montani J-P, et al. Exposure to a high fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension. 2010;55:862–8. This study highlights the importance of appropriate normalization of directly recorded renal SNA in two groups of rabbits, one fed a normal diet and one fed a high-fat diet. By normalizing SNA to the nasopharyngeal response, the researchers determined that the fat-fed rabbits had markedly higher renal SNA than the controls and that this was due to an increase in burst amplitude, not frequency. PubMedCrossRef

23.

Burke SL, Evans RG, Moretti J-L, Head GA. Levels of renal and extrarenal sympathetic drive in Ang II-induced hypertension. Hypertension. 2008;51:878–83.PubMedCrossRef

24.

Samuelsson AM, Morris A, Igosheva N, Kirk SL, Pombo JM, Coen CW, et al. Evidence for sympathetic origins of hypertension in juvenile offspring of obese rats. Hypertension. 2010;55:76–82.PubMedCrossRef

25.

Moretti J-L, Burke SL, Evans RG, Lambert GW, Head GA. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to Angiotensin II-induced hypertension. J Hypertens. 2009;27:1838–48.PubMedCrossRef

26.

Jones PP, Shapiro LF, Keisling GA, Jordan J, Shannon JR, Quaife RA, et al. Altered autonomic support of arterial blood pressure with age in healthy men. Circulation. 2001;104:2424–9.PubMedCrossRef

27.

Diedrich A, Jordan J, Tank J, Shannon JR, Robertson R, Luft FC, et al. The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade. J Hypertens. 2003;21:1677–86.PubMedCrossRef

28.

Malpas SC. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol. 2002;282:H6–H20.

29.

Kopin IJ, Rundqvist B, Friberg P, Lenders J, Goldstein DS, Eisenhofer G. Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm. Am J Physiol. 1998;275:R165–73.PubMed

30.

Noshiro T, Saigusa T, Way D, Dorward PK, McGrath BP. Norepinephrine spillover faithfully reflects renal sympathetic nerve activity in conscious rabbits. Am J Physiol. 1991;261:F44–50.PubMed

31.

Wallin BG, Delius W, Hagbarth KE. Comparison of sympathetic nerve activity in normotensive and hypertensive subjects. Circ Res. 1973;33:9–21.PubMed

32.

Sundlof G, Wallin BG. The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol. 1977;272:383–97.PubMed

33.

Malpas SC, Bendle RD, Head GA, Ricketts JH. Frequency and amplitude of sympathetic discharges by baroreflexes during hypoxia in conscious rabbits. Am J Physiol. 1996;271:H2563–74.PubMed

34.

Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E, et al. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension. 2007;50:862–8.PubMedCrossRef

35.

• Lambert E, Dawood T, Straznicky N, Sari C, Schlaich M, Esler M, et al. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens. 2010;28:543–50. These investigators examined both multi-unit SNA and single-unit SNA from the peroneal nerve in patients with metabolic syndrome in relation to their underlying anxiety levels. They found that although multi-unit SNA was not related to anxiety levels, there was a strong association between the firing pattern of single-unit SNA and anxiety and depression. This study highlights the importance of analyzing single-unit firing properties as well as multi-unit data to ensure that disturbed firing patterns may be detected. PubMedCrossRef

36.

Macefield V, Wallin B, Vallbo A. The discharge behaviour of single vasoconstrictor montoneurones in human muscle nerves. J Physiol. 1994;491:799–809.

37.

Macefield VG, Wallin BG. Firing properties of single vasoconstrictor neurones in human subjects with high levels of muscle sympathetic activity. J Physiol. 1999;516(Pt 1):293–301.PubMedCrossRef

38.

Murai H, Takamura M, Maruyama M, Nakano M, Ikeda T, Kobayashi D, et al. Altered firing pattern of single-unit muscle sympathetic nerve activity during handgrip exercise in chronic heart failure. J Physiol. 2009;587:2613–22.PubMedCrossRef

39.

Elam M, Macefield V. Multiple firing of single muscle vasoconstrictor neurons during cardiac dysrhythmias in human heart failure. J Appl Physiol. 2001;91:717–24.PubMed

40.

Lambert E, Dawood T, Schlaich M, Straznicky N, Esler M, Lambert G. Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk. Clin Exp Pharmacol Physiol. 2008;35:503–7.PubMedCrossRef

41.

Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001;58:221–7.PubMedCrossRef

42.

Dibona GF, Sawin LL. Functional significance of the pattern of renal sympathetic nerve activation. Am J Physiol. 1999;277:R346–53.PubMed

43.

Burns J, Sivananthan MU, Ball SG, Mackintosh AF, Mary DA, Greenwood JP. Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension. Circulation. 2007;115:1999–2005.PubMedCrossRef

44.

Iriki M, Riedel W, Simon E. Regional differentiation of sympathetic activity during hypothalamic heating and cooling in anesthetized rabbits. Pflugers Arch. 1971;328:320–31.PubMedCrossRef

45.

Dorward PK, Riedel W, Burke SL, Gipps J, Korner PI. The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ Res. 1985;57:618–33.PubMed

46.

Miki K, Kosho A, Hayashida Y. Method for continuous measurements of renal sympathetic nerve activity and cardiovascular function during exercise in rats. Exp Physiol. 2002;87:33–9.PubMedCrossRef

47.

• Yoshimoto M, Miki K, Fink GD, King A, Osborn JW. Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats. Hypertension. 2010;55:644–51. In this study, both renal and lumbar SNA were recorded continuously from rats on a high-salt diet for up to 1 month after implantation of an electrode. To determine the effects of angiotensin administration on SNA, the study included a recovery from drug treatment to account for decay in the recording signal. The results showed that the renal and lumbar vascular beds are differentially modulated by angiotensin. PubMedCrossRef

48.

Head GA, Burke SL. Sympathetic responses to stress and rilmenidine in 2K1C hypertensive rabbits: evidence of enhanced non-vascular neuroeffector mechanism. Hypertension. 2004;43:636–42.PubMedCrossRef

49.

Burke SL, Head GA. Method for in-vivo calibration of renal sympathetic nerve activity in rabbits. J Neurosci Meth. 2003;127:63–74.CrossRef

50.

Guild SJ, Barrett CJ, McBryde FD, Van Vliet BN, Head GA, Burke SL, et al. Quantifying sympathetic nerve activity; problems and pitfalls, the need for standardization. Exp Physiol. 2010;95:41–50.PubMedCrossRef

51.

Mark AL, Agassandian K, Morgan DA, Liu X, Cassell MD, Rahmouni K. Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney. Hypertension. 2009;53:375–80.PubMedCrossRef

52.

Morgan DA, Rahmouni K. Differential effects of insulin on sympathetic nerve activity in agouti obese mice. J Hypertens. 2010;28:1913–9.PubMedCrossRef

53.

Dos Santos FM, Martins Dias DP, da Silva CA, Fazan Jr R, Salgado HC. Sympathetic activity is not increased in L-NAME hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2010;298:R89–95.PubMedCrossRef

54.

Ma X, Abboud FM, Chapleau MW. Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice. Am J Physiol Regul Integr Comp Physiol. 2002;283:R1033–40.PubMed

55.

Huber DA, Schreihofer AM. Attenuated baroreflex control of sympathetic nerve activity in obese Zucker rats by central mechanisms. J Physiol. 2010;588:1515–25.PubMedCrossRef

56.

Nishi EE, Oliveira-Sales EB, Bergamaschi CT, Oliveira TG, Boim MA, Campos RR. Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats. Am J Hypertens. 2010;23:473–80.PubMedCrossRef

57.

• Burke SL, Evans RG, Head GA. Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension. Brit J Pharmacol. 2010;159:438–48. This study demonstrated that chronic sympathoinhibition is an effective antihypertensive therapy in a rabbit model of renovascular (2K1C) hypertension. Sympathoinhibition normalized mean arterial pressure (MAP) and reduced basal plasma renin activity (PRA) without compromising blood flow in the stenosed kidney or altering responses of MAP, hemodynamics, and PRA to acute hypotension and stress. CrossRef

58.

Peterson DF, Coote JH, Gilbey MP, Futuro-Neto HA. Differential pattern of sympathetic outflow during upper airway stimulation with smoke. Am J Physiol. 1983;245:R433–7.PubMed

59.

Barrett CJ, Ramchandra R, Guild SJ, Lala A, Budgett DM, Malpas SC. What sets the long-term level of renal sympathetic nerve activity—a role for angiotensin II and baroreflexes? Circ Res. 2003;92:1330–6.PubMedCrossRef

60.

Panneton WM, Gan Q, Juric R. The rat: a laboratory model for studies of the diving response. J Appl Physiol. 2010;108:811–20.PubMedCrossRef

61.

• Booth LC, Bennet L, Guild SJ, Barrett CJ, May CN, Gunn AJ, et al. Maturation-related changes in the pattern of renal sympathetic nerve activity from fetal life to adulthood. Exp Physiol. 2011;96(2):85–93. These investigators report the use of a telemetric SNA recording electrode in unanesthetized fetal sheep. The study highlights the applicability of this new technology to different species and experimental settings. PubMed

62.

Guild SJ, Barrett CJ, McBryde FD, Van Vliet BN, Malpas SC. Sampling of cardiovascular data; how often and how much? Am J Physiol Regul Integr Comp Physiol. 2008;295:R510–5.PubMedCrossRef

63.

Butz GM, Davisson RL. Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics. 2001;5:89–97.PubMed

Title: New Approaches to Quantifying Sympathetic Nerve Activity
Authors: Sandra L. Burke
Elisabeth Lambert
Geoffrey A. Head
Publication date: 01-06-2011
Publisher: Current Science Inc.
Published in: Current Hypertension Reports / Issue 3/2011
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI: https://doi.org/10.1007/s11906-011-0196-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2011

Vitamin D Therapy and Cardiovascular Health

Sympathetic Neural Mechanisms in Human Blood Pressure Regulation

Stress and Its Role in Sympathetic Nervous System Activation in Hypertension and the Metabolic Syndrome

Neural Mechanisms of Angiotensin II–Salt Hypertension: Implications for Therapies Targeting Neural Control of the Splanchnic Circulation

Vascular Mechanisms in the Pathogenesis of Stroke

Does Blood Pressure Variability Modulate Cardiovascular Risk?

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials